Items where Author is "Mcardle, SE"
 | Up a level |
Journal article
MATHIEU, M.G., KNIGHTS, A.J., PAWELEC, G., RILEY, C.L., WERNET, D., LEMONNIER, F.A., STRATEN, P.T., MUELLER, L., REES, R.C. and MCARDLE, S.E., 2007. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy, 56 (12), pp. 1885-1895. ISSN 0340-7004
HORTON, R.B.V., LAVERSIN, S.A.S., REEDER, S.P., REES, R.C. and MCARDLE, S.E., 2007. Identification of immunogenic MHC class II tyrosinase-derived peptides using HLA-DR1 and HLA-DR4 transgenic mice. Protein and Peptide Letters, 14 (5), pp. 455-460. ISSN 0929-8665
ASSUDANI, D.P., HORTON, R.B.V., MATHIEU, M.G., MCARDLE, S.E. and REES, R.C., 2007. The role of CD4(+) T cell help in cancer immunity and the formulation of novel cancer vaccines. Cancer Immunology Immunotherapy, 56 (1), pp. 70-80. ISSN 0340-7004
ALI, S.A., AHMAD, M., LYNAM, J., MCLEAN, C.S., ENTWISLE, C., LOUDON, P., CHOOLUN, E., MCARDLE, S.E., LI, G., MIAN, S. and REES, R.C., 2004. Anti-tumour therapeutic efficacy of OX40L in murine tumour model. Vaccine, 22 (2728), pp. 3585-3594. ISSN 0264-410X
KNIGHTS, A.J., MCARDLE, S.E., MÜLLER, L., MCCULLOCH, T.A., REES, R.C. and PAWELEC, G., 2004. Identification of a novel epitope derived from the cancer-germline antigen, HAGE, displaying both in-vitro and in-vivo immunogenicity. Cancer Cell International, 41 (350). ISSN 1475-2867
PARKINSON, R.J., MIAN, S., BISHOP, M.C., GRAY, T., LI, G., MCARDLE, S.E., ALI, S. and REES, R.C., 2003. Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy. Prostate, 56 (1), pp. 65-73. ISSN 0270-4137
ALI, S.A., LYNAM, J., MCLEAN, C.S., ENTWISLE, C., LOUDON, P., ROJAS, J.M., MCARDLE, S.E., LI, G., MIAN, S. and REES, R.C., 2002. Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity. Journal of Immunology, 168 (7), pp. 3512-3519. ISSN 0022-1767
MCARDLE, S.E., REES, R.C., MULCAHY, K.A., SABA, J., MCINTYRE, C.A. and MURRAY, A.K., 2000. Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant. Cancer Immunology Immunotherapy, 49 (8), pp. 417-425. ISSN 0340-7004
